Andrew Menzies Gow | Lungemedisin | November 30, 2018
Which asthmatic patiemts should be offered biological treatment and how do we differentiate between the individual biological drugs? What is the future for the patients? These are some of the issues raised by Professor Andrew Menzies Gow, Royal Brompton Hospital, London, in this MEDtalk. Listen and see if you agree!